Westlake Chemical Partners LP () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1282122,
    "name": "Westlake Chemical Partners LP",
    "stock_name": "Westlake Chemical Partners LP",
    "full_name": "Westlake Chemical Partners LP",
    "name_url": "stocks-analysis/westlake-chemical-partners-lp",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "18.93",
    "chg": -0.07,
    "chgp": "-0.37%",
    "dir": -1,
    "prev_price": "19.00",
    "mcapval": "774.19",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Specialty Chemicals",
    "ind_code": 2210,
    "indexname": "S&P 500",
    "isin": "US9604171036",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "98.46 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/westlake-chemical-partners-lp-1282122-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Westlake Chemical Partners LP overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-westlake-chemical-partners-lp-overvalued-or-undervalued-3673402",
        "imagepath": "",
        "date": "2025-11-05 11:10:49",
        "description": "As of 31 October 2025, the valuation grade for Westlake Chemical Partners LP has moved from fair to attractive, indicating a more favorable assessment of its value. The company appears undervalued, with a P/E ratio of 2, significantly lower than its peers such as Kronos Worldwide, Inc. with a P/E of 10.01, and Advansix, Inc. at 8.36. Additionally, Westlake's EV to EBITDA ratio stands at 2.50, which is competitive compared to the industry average, suggesting potential for growth.\n\nIn terms of performance metrics, Westlake boasts a robust ROE of 63.47% and an impressive ROCE of 39.90%, highlighting its efficient use of equity and capital. However, the company's stock has underperformed relative to the S&P 500, with a year-to-date return of -20.05% compared to the index's 16.30%. This disparity reinforces the notion that the stock may be undervalued, presenting a potential buying opportunity for investors...."
      },
      {
        "title": "Is Westlake Chemical Partners LP overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-westlake-chemical-partners-lp-overvalued-or-undervalued-3670596",
        "imagepath": "",
        "date": "2025-11-04 11:16:47",
        "description": "As of 31 October 2025, the valuation grade for Westlake Chemical Partners LP moved from fair to attractive, indicating a shift towards a more favorable assessment. The company appears undervalued, with a P/E ratio of 2, significantly lower than its peers, such as Kronos Worldwide, Inc. at 10.01 and Advansix, Inc. at 8.36. Additionally, Westlake's EV to EBITDA stands at 2.50, while the industry average is considerably higher, further supporting the undervaluation thesis.\n\nIn terms of performance, Westlake Chemical has underperformed relative to the S&P 500 across multiple periods, with a year-to-date return of -19.32% compared to the S&P 500's 16.30%. This trend continues over one year and three years, where Westlake's returns of -16.47% and -20.32% starkly contrast with the S&P 500's 19.89% and 76.66%, respectively. Overall, the combination of low valuation ratios and poor stock performance relative to the ..."
      },
      {
        "title": "Is Westlake Chemical Partners LP overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-westlake-chemical-partners-lp-overvalued-or-undervalued-3666161",
        "imagepath": "",
        "date": "2025-11-03 11:16:13",
        "description": "As of 31 October 2025, the valuation grade for Westlake Chemical Partners LP moved from fair to attractive, indicating a more favorable assessment of its worth. The company appears undervalued, supported by a low P/E ratio of 2, a price-to-book value of 1.54, and an EV to EBITDA ratio of 2.50. In comparison to peers, Westlake's P/E ratio is significantly lower than that of Kronos Worldwide, Inc. at 10.01 and Advansix, Inc. at 8.36, reinforcing the notion of undervaluation.\n\nDespite the attractive valuation metrics, Westlake has underperformed against the S&P 500, with a year-to-date return of -18.50% compared to the index's 16.30%. This underperformance over multiple periods suggests that while the company may be undervalued based on its financial ratios, market sentiment has not yet aligned with its intrinsic value...."
      },
      {
        "title": "Is Westlake Chemical Partners LP overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-westlake-chemical-partners-lp-overvalued-or-undervalued-3664294",
        "imagepath": "",
        "date": "2025-11-02 11:09:12",
        "description": "As of 31 October 2025, the valuation grade for Westlake Chemical Partners LP moved from fair to attractive, indicating a more favorable outlook. The company appears undervalued, supported by a P/E ratio of 2, an EV/EBITDA of 2.50, and a Price to Book Value of 1.54. In comparison, peers such as Kronos Worldwide, Inc. have a P/E of 10.01 and an EV/EBITDA of 7.10, while Advansix, Inc. shows a P/E of 8.36 and an EV/EBITDA of 5.58, highlighting Westlake's relative undervaluation in the specialty chemicals sector.\n\nDespite the attractive valuation metrics, Westlake Chemical Partners LP has underperformed against the S&P 500, with a year-to-date return of -18.50% compared to the index's 16.30%. This underperformance over multiple periods suggests that while the stock may be undervalued, market sentiment has not yet reflected this potential...."
      },
      {
        "title": "Westlake Chemical Partners LP Hits New 52-Week Low at $18.38",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/westlake-chemical-partners-lp-hits-new-52-week-low-at-1838-3661963",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/WestlakeChemica_priceRelatedfactors_3661963.png",
        "date": "2025-10-31 16:16:49",
        "description": "Westlake Chemical Partners LP has hit a new 52-week low, reflecting a notable decline in its stock price over the past year. The company, with a market cap of USD 774 million, faces challenges in long-term growth, evidenced by declining operating profits and rising raw material costs."
      },
      {
        "title": "Westlake Chemical Partners LP Hits New 52-Week Low at $18.93",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/westlake-chemical-partners-lp-hits-new-52-week-low-at-1893-3659140",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/WestlakeChemica_priceRelatedfactors_3659140.png",
        "date": "2025-10-30 18:37:44",
        "description": "Westlake Chemical Partners LP has reached a new 52-week low, reflecting a notable decline in its stock price over the past year. The company, with a market capitalization of USD 774 million, has faced challenges including a decrease in operating profit and a recent drop in net profit, despite a strong return on equity."
      },
      {
        "title": "Westlake Chemical Partners LP Hits New 52-Week Low at $20.52",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/westlake-chemical-partners-lp-hits-new-52-week-low-at-2052-3622793",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/WestlakeChemica_priceRelatedfactors_3622793.png",
        "date": "2025-10-15 16:59:05",
        "description": "Westlake Chemical Partners LP has hit a new 52-week low, reflecting a notable decline in its stock price over the past year. The company, categorized as a microcap stock, faces challenges such as decreasing operating profit growth and rising raw material costs, despite a high return on equity."
      },
      {
        "title": "Westlake Chemical Partners Hits 52-Week Low at USD 20.63",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/westlake-chemical-partners-hits-52-week-low-at-usd-2063-3571322",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/WestlakeChemica_priceRelatedfactors_3571322.png",
        "date": "2025-09-25 16:45:09",
        "description": "Westlake Chemical Partners LP has reached a new 52-week low, reflecting ongoing challenges in the specialty chemicals sector. The company has a market capitalization of USD 774 million and a low P/E ratio, alongside a high return on equity. However, it faces declining operating profit growth and a significant drop in net profit."
      },
      {
        "title": "Westlake Chemical Partners LP Hits New 52-Week Low at $21.00",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/westlake-chemical-partners-lp-hits-new-52-week-low-at-2100-3565290",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/WestlakeChemica_priceRelatedfactors_3565290.png",
        "date": "2025-09-24 13:29:05",
        "description": "Westlake Chemical Partners LP has hit a new 52-week low, trading at USD 21.00 as of September 23, 2025. The company has experienced a 7.28% decline in stock price over the past year, alongside a decrease in operating profit and net profit, despite a strong return on equity."
      }
    ],
    "total": 15,
    "sid": "1282122",
    "stock_news_url": "https://www.marketsmojo.com/news/westlake-chemical-partners-lp-1282122"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Westlake Chemical Partners LP overvalued or undervalued?

2025-11-05 11:10:49

As of 31 October 2025, the valuation grade for Westlake Chemical Partners LP has moved from fair to attractive, indicating a more favorable assessment of its value. The company appears undervalued, with a P/E ratio of 2, significantly lower than its peers such as Kronos Worldwide, Inc. with a P/E of 10.01, and Advansix, Inc. at 8.36. Additionally, Westlake's EV to EBITDA ratio stands at 2.50, which is competitive compared to the industry average, suggesting potential for growth. In terms of performance metrics, Westlake boasts a robust ROE of 63.47% and an impressive ROCE of 39.90%, highlighting its efficient use of equity and capital. However, the company's stock has underperformed relative to the S&P 500, with a year-to-date return of -20.05% compared to the index's 16.30%. This disparity reinforces the notion that the stock may be undervalued, presenting a potential buying opportunity for investors....

Is Westlake Chemical Partners LP overvalued or undervalued?

2025-11-04 11:16:47

As of 31 October 2025, the valuation grade for Westlake Chemical Partners LP moved from fair to attractive, indicating a shift towards a more favorable assessment. The company appears undervalued, with a P/E ratio of 2, significantly lower than its peers, such as Kronos Worldwide, Inc. at 10.01 and Advansix, Inc. at 8.36. Additionally, Westlake's EV to EBITDA stands at 2.50, while the industry average is considerably higher, further supporting the undervaluation thesis. In terms of performance, Westlake Chemical has underperformed relative to the S&P 500 across multiple periods, with a year-to-date return of -19.32% compared to the S&P 500's 16.30%. This trend continues over one year and three years, where Westlake's returns of -16.47% and -20.32% starkly contrast with the S&P 500's 19.89% and 76.66%, respectively. Overall, the combination of low valuation ratios and poor stock performance relative to the ...

Is Westlake Chemical Partners LP overvalued or undervalued?

2025-11-03 11:16:13

As of 31 October 2025, the valuation grade for Westlake Chemical Partners LP moved from fair to attractive, indicating a more favorable assessment of its worth. The company appears undervalued, supported by a low P/E ratio of 2, a price-to-book value of 1.54, and an EV to EBITDA ratio of 2.50. In comparison to peers, Westlake's P/E ratio is significantly lower than that of Kronos Worldwide, Inc. at 10.01 and Advansix, Inc. at 8.36, reinforcing the notion of undervaluation. Despite the attractive valuation metrics, Westlake has underperformed against the S&P 500, with a year-to-date return of -18.50% compared to the index's 16.30%. This underperformance over multiple periods suggests that while the company may be undervalued based on its financial ratios, market sentiment has not yet aligned with its intrinsic value....

Is Westlake Chemical Partners LP overvalued or undervalued?

2025-11-02 11:09:12

As of 31 October 2025, the valuation grade for Westlake Chemical Partners LP moved from fair to attractive, indicating a more favorable outlook. The company appears undervalued, supported by a P/E ratio of 2, an EV/EBITDA of 2.50, and a Price to Book Value of 1.54. In comparison, peers such as Kronos Worldwide, Inc. have a P/E of 10.01 and an EV/EBITDA of 7.10, while Advansix, Inc. shows a P/E of 8.36 and an EV/EBITDA of 5.58, highlighting Westlake's relative undervaluation in the specialty chemicals sector. Despite the attractive valuation metrics, Westlake Chemical Partners LP has underperformed against the S&P 500, with a year-to-date return of -18.50% compared to the index's 16.30%. This underperformance over multiple periods suggests that while the stock may be undervalued, market sentiment has not yet reflected this potential....

Westlake Chemical Partners LP Hits New 52-Week Low at $18.38

2025-10-31 16:16:49

Westlake Chemical Partners LP has hit a new 52-week low, reflecting a notable decline in its stock price over the past year. The company, with a market cap of USD 774 million, faces challenges in long-term growth, evidenced by declining operating profits and rising raw material costs.

Westlake Chemical Partners LP Hits New 52-Week Low at $18.93

2025-10-30 18:37:44

Westlake Chemical Partners LP has reached a new 52-week low, reflecting a notable decline in its stock price over the past year. The company, with a market capitalization of USD 774 million, has faced challenges including a decrease in operating profit and a recent drop in net profit, despite a strong return on equity.

Westlake Chemical Partners LP Hits New 52-Week Low at $20.52

2025-10-15 16:59:05

Westlake Chemical Partners LP has hit a new 52-week low, reflecting a notable decline in its stock price over the past year. The company, categorized as a microcap stock, faces challenges such as decreasing operating profit growth and rising raw material costs, despite a high return on equity.

Westlake Chemical Partners Hits 52-Week Low at USD 20.63

2025-09-25 16:45:09

Westlake Chemical Partners LP has reached a new 52-week low, reflecting ongoing challenges in the specialty chemicals sector. The company has a market capitalization of USD 774 million and a low P/E ratio, alongside a high return on equity. However, it faces declining operating profit growth and a significant drop in net profit.

Westlake Chemical Partners LP Hits New 52-Week Low at $21.00

2025-09-24 13:29:05

Westlake Chemical Partners LP has hit a new 52-week low, trading at USD 21.00 as of September 23, 2025. The company has experienced a 7.28% decline in stock price over the past year, alongside a decrease in operating profit and net profit, despite a strong return on equity.

View All News